|
Press Releases |
|
|
|
Friday, September 23, 2022 |
|
Malaysian Genomics Grows Presence in Thailand |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce today a series of collaborations to grow its customer base in Thailand as well as exploring opportunities for research and development (R&D) of new products and services. more info >> |
|
Wednesday, September 21, 2022 |
|
Malaysian Genomics, Rinani Genotec Sign LOI with Universiti Malaysia Sabah |
Leading genomics and biopharmaceutical specialist Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155) is pleased to report that the Group has signed a letter of intent (LOI) with the Faculty of Science and Natural Resources, Universiti Malaysia Sabah (UMS) and Rinani Genotec Sdn Bhd (Genotec) to collaborate on research and development (R&D) in genetics, and regenerative and alternative medicines. more info >> |
|
Tuesday, August 30, 2022 |
|
Malaysian Genomics Reports RM28.36 Million Full-Year Revenue |
Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, reported revenue of RM6.33 million for the fourth quarter ended 30 June 2022 (4Q 2022) compared with the loss of RM0.07 million in the corresponding quarter of the previous financial year (4Q 2021) on higher contribution from the biopharmaceutical business and continued organic growth of the genetic testing business. more info >> |
|
Monday, August 29, 2022 |
|
Malaysian Genomics Signs MoU with Ajlan to explore distribution of biopharmaceutical and genetic screening services in MENA region |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, today announced that the Group has signed a Memorandum of Understanding (MoU) to explore opportunities for the distribution of biopharmaceutical and genomics products and services with Ajlan & Bros Medical Company. more info >> |
|
Thursday, August 18, 2022 |
|
Malaysian Genomics Explores Strategic Partnership with MAHSA Health through MoU |
Malaysian Genomics Resource Centre Berhad's (Bursa: MGRC, 0155) wholly-owned subsidiary, MGRC Therapeutics Sdn. Bhd. signed a memorandum of understanding (MoU) with MAHSA Health Sdn Bhd to discuss the formation of a strategic partnership promoting practice-based education, research and knowledge exchange. more info >> |
|
Wednesday, July 20, 2022 |
|
UCrest Partners with Malaysian Genomics to Digitalize Genome Services Worldwide |
UCrest Berhad (ACE Market: 0005) and Malaysian Genomics Resources Centre Berhad, (ACE Market: 0155) announced today that they have signed a collaborative agreement to integrate genomic testing services into digital health platform, iMedic(TM), elevating healthcare services to the next level. more info >> |
|
Friday, July 15, 2022 |
|
Malaysian Genomics Appoints New Chairman |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that the Company has appointed Dato' Seri Dr Chen Chaw Min as the Independent Non-Executive Chairman of the Board of Directors. more info >> |
|
Wednesday, July 13, 2022 |
|
Malaysian Genomics Forms Partnership for Expansion in Saudi Arabia |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that it has entered into a strategic partnership with United Doctors Hospital (UDH) for collaboration in genomics and cell therapies. more info >> |
|
Friday, July 8, 2022 |
|
Malaysian Genomics Proposes Private Placement |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that the Group is proposing to undertake a private placement of up to 10% of its total number of issued shares or up to 12.42 million new placement shares at an issue price to be determined for third-party investors that will be identified later. more info >> |
|
Wednesday, July 6, 2022 |
|
Malaysian Genomics to Offer First-Ever Sports-Based Tests Specific to Southeast Asian Genetic Profiles |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce that the Group's wholly-owned subsidiary, MGRC Therapeutics Sdn Bhd (MGRCT), is collaborating with Rinani Genotec Sdn Bhd (Genotec) to offer sports-based genetic tests. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
New Contaminants, Food Testing & More: analytica Convention 2024 Focuses on Vietnam's Laboratory Needs
Apr 23, 2024 16:00 HKT/SGT
|
|
|
多元产品夯实核心竞争力 泛娱乐产品龙头卡游拟赴港IPO
Apr 23, 2024 15:25 HKT/SGT
|
|
|
多元產品夯實核心競爭力 泛娛樂產品龍頭卡游擬赴港IPO
Apr 23, 2024 15:20 HKT/SGT
|
|
|
Singapore Unveils Its First Live Painting Event Featuring ADHD Artists, Inspired by 'Collide' by Tay Guan Hin"
Apr 23, 2024 14:28 HKT/SGT
|
|
|
EM2AI Revolutionising the Dental Industry: New AI Products Promise Transparent Treatment Plans for Patients
Apr 23, 2024 14:00 HKT/SGT
|
|
|
Vietnam: Nutifood opts for innovative SIG DomeMini on-the-go carton bottle
Apr 23, 2024 14:00 HKT/SGT
|
|
|
Citi, UBS, GS view positive on Fosun's core business-focused strategy
Apr 23, 2024 13:28: JST
|
|
|
大行花旗、瑞银、高盛等持续看好复星国际聚焦主业战略
Apr 23, 2024 12:38 HKT/SGT
|
|
|
大行花旗、瑞銀、高盛等持續看好復星國際聚焦主業戰略
Apr 23, 2024 12:33 HKT/SGT
|
|
|
Citi, UBS, GS view positive on Fosun's core business-focused strategy
Apr 23, 2024 12:28 HKT/SGT
|
|
|
Indonesia Ready to Lead Water Governance Transformation at the 10th World Water Forum
Apr 23, 2024 12:00 HKT/SGT
|
|
|
「富士通SX調査レポート2024」を公開、サステナビリティ経営成功のカギはデータ利活用
Apr 23, 2024 10:00: JST
|
|
|
(Second overseas roadshow of 2024) MGTO unveils mega roadshow and presentation seminar in Singapore this Thursday (25 April) to tap into overseas markets
Apr 23, 2024 10:00 HKT/SGT
|
|
|
Beyond Centralization: Exploring a New Era at the World Blockchain Summit
Apr 23, 2024 09:47 HKT/SGT
|
|
|
Fujitsu SX Survey reveals key success factors for sustainability
Apr 23, 2024 10:25 JST
|
|
|
|
More News >> |
|
|
|
|
|